Look at the bump in CVM calls
alsp
Posts
-
-
Geert should have been fired long ago.
How many years did they lose with the company he hired to oversee testing initially? Studies finally show efficacy with 0 toxicity yet no approval. Why even have a BOD? -
. Consequently, in order to stimulate product development and innovation, Congress in 1984 enacted Title II of the Drug Price Competition and Patent Term Restoration Act (Public Law 98-417) to extend patent life to compensate patent holders for marketing time lost while developing the product and awaiting government approval. Title II of the Act created a program whereby patent holders whose patents claim a human drug product, medical device, food additive or color additive could recoup some of the lost patent time.
-
MK would be classified as an orphan drug.
It treats a condition with no real new types of therapy in decades and - importantly - has ZERO toxicity. There is already enough data for approval for such a drug.. Companies like Merck most likely have franchise drugs that Keytruda in H&N cancer trials. The FDA is being bought off to protect such franchise drugs. My question is has Geert been bought off as well. As soon as CVM is bled dry and sold to a big pharma company for $20/s, MK will amazingly get fast track approval. That’s a far cry from the $150-$200/sh a stand alone CVM would bring with approval. -
MK would be classified as an orphan drug.
It treats a condition with no real new types of therapy in decades and - importantly - has ZERO toxicity. There is already enough data for approval for such a drug.. Companies like Merck most likely have franchise drugs that Keytruda in H&N cancer trials. The FDA is being bought off to protect such franchise drugs. My question is has Geert been bought off as well. As soon as CVM is bled dry and sold to a big pharma company for $20/s, MK will amazingly get fast track approval. That’s a far cry from the $150-$200/sh a stand alone CVM would bring with approval. -
A vaccine that kills children gets approved but a drug that saves lives gets ignored. I keep telling you people the FDA is not about saving lives
https://www.igor-chudov.com?utm_source=navbar&utm_medium=web
-
Why isn’t Geert in front of a microphone touting his life saving drug? How can such an ineffective CEO last so long? This has been going on for over THIRTY YEARS!
-
If the FDA was about saving lives, they would never have demonized ivermectin nor would they still be pushing the COVID vaccine. MK will not be approved until it is submitted by BIG pharma. - not bc of the lives it will save - but bc of the money it will make.
-
Who posted the Trump disinformation? Trump only asked there be an investigation - esp in light of the early morning ballot dumps after the ‘water main’ break. We have enough headaches with Geert. Let’s focus on that. Go to an MSNBC board if you want to hate on Trump and ignore the Biden crime family.
-
How has Geert remained CEO for so long with all of the delays and lack of approval?
Firing him would raise awareness of MK and give stock price a bump. This smells. -
The same FDA that approves a dangerous COVID vaccine for children will not approve a lifesaving NON TOXIC treatment for adults with cancer. People need to understand this is more about politics, payoffs and agendas rather than medicine and healing. No vaccine with the side effects documented with the COVID vaccine would have ever gotten such widespread regulatory approval in the past. I have been following MK since 1990. It should have received some type of limited approval long ago.
-
Where are the lawyers? Good data. Orphan drug. No approval. Who is benefiting from this slow walking of approval? Certainly not the shareholders.
-
Where are the lawyers? There is more than enough data for approval. Something stinks
-
Do comments accusing big pharma of being involved in delayed approval of FDA get shadow banned?
-
MK should have received orphan drug status by now. This process is corrupt.
Drug being slow walked. -
V, your post is the likely future of CVM. Merck will buy them for $40 instead of the $140 ticket price you will see with an IPO
-
How many of you know that both Opdivo and Keytruda are both approved for head and neck cancer patients that fail Conventional chemotherapy? The FDA has exhibited how corrupt they are by suppressing the use of effective treatments, like ivermectin and promoting a flawed, clearly dangerous Covid vax. Don’t think this corruption doesn’t extend to other therapeutics as well. Big Pharma will do whatever it takes to protect their franchise drugs. Nothing else explains why a non-toxic therapy for a fatal disease with proven efficacy has taken so long to get approval.
-
This is a $200 stock with US approval which is the pot of gold long term shareholders have been waiting for - not a $40 buyout.
-
I will tell you why, Ted. The FDA is just another corrupt government 3 later agency. They are wholly owned by big pharma. Why else would the recommend a toxic COViD vax for children when it is known it does NOT prevent transmission and in this age group the potential complications are far worse than the minuscule benefits in this age group. The FDA is not on the side of life and health - otherwise MK would have been already approved. CVM - perhaps with the blessing of their CEO - is being bled dry of funds to facilitate a fire sale to big pharma. This is a $200 stock that will be sold for $20-$30..
-
Only a reckless fool would stay short -at least near term - on CVM based on this recent application.
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM
CVM